Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Neural stimulation is an established therapy for the treatment of chronic pain ( ), movement disorders ( ), epilepsy ( ), and urinary and bowel control ( ), and is now being investigated for numerous other psychological and neurological disorders. For many neuromodulation systems therapy parameter determination is limited to physician programming, resulting in parameters that are static between clinic visits, potentially for months at a time. Programming adjustments can lag patient need considerably, because fluctuations in disease symptoms or the user’s body can change within weeks, days, or hours. To allow more flexible therapy, most systems give patients the ability to change stimulation parameters manually, with a choice of preset programs within preset ranges. However, manual adjustment does not ensure optimal therapy use and places the burden on the patient. Devices that automatically change in response to patient need ( Fig. 23.1 ) may help to provide consistent therapy, reduce the side-effects of overtreatment or undertreatment, and improve battery longevity by providing therapy only when needed. This sort of automaticity may also lower the burden associated with manual adjustments.
Systems that adapt therapy in response to physiological changes have already begun to appear in clinical practice ( ). This review focuses on the current status of three neuromodulation therapies that leverage closed-loop control: spinal cord stimulation (SCS) for treatment of pain; cortical and vagus nerve stimulation for treatment of epilepsy; and deep brain stimulation (DBS) for treatment of movement disorders. Each section reviews the history and scientific background of the therapy, and then examines the current state of closed-loop control. Finally, looking forward to the needs of new systems, a set of strategies that can be used in developing new systems is presented.
First approved by the United States Food and Drug Administration (FDA) in 1989, SCS has become a common intervention for patients with chronic pain in their back or limbs and represents nearly 70% of all neuromodulation treatments ( ). Despite the significant therapeutic benefit of the open-loop therapy, patients use their remote programmers to adjust for changes in pain intensity or body posture. Changes in body position are known to affect the perceived stimulation effect ( ). At the same stimulation settings, the paresthesia is usually perceived more intensely in the supine position than in an upright position. This position dependency is thought to be due to changes in the thickness of the cerebrospinal fluid layer around the spinal cord rather than to dislocation of the electrode or changes in electrode impedance ( ). Automatic adjustment of stimulation intensity and other parameters such as electrode configuration to account for spinal cord movement would help maintain consistent therapy and lower the burden associated with frequent use of the remote programmer.
At least two feedback signals have been identified for closed-loop control of stimulation adjustments related to spinal cord movement. For adapting stimulation based on body posture, motion sensors such as accelerometers can be used to provide a straightforward feedback signal for the control policy ( ). Feedback based on accelerometry, however, only addresses therapy needs when defined patient positions change; it does not address spinal cord movement in a static position or rotational spine or body movement. Electrophysiological biomarkers have been investigated as a mechanism to monitor these aspects of spinal cord stimulation objectively. Recordings of the evoked compound action potential (ECAP) from epidural electrodes in humans have shown some potential as an indicator of pain and anatomy ( ). A correlation between ECAP magnitude and thresholds for stimulation was demonstrated, showing that ECAPs may provide appropriate feedback on therapy parameters. Additionally, the magnitude of the ECAP was correlated with the degree of coverage of the painful area. ECAP localization may help in finding the best position for electrode implantation. This feedback during the lead placement procedure has the potential to provide clinical data in real time to enable optimal and objective placement of the electrode with respect to the spinal cord, without having to rely solely on patient cues.
The RestoreSensor system uses a three-axis accelerometer to sense patient body position and automatically adjust the stimulation settings ( Fig. 23.2 ). An initial calibration is required, during which the patient is positioned in multiple orientations (e.g., standing, lying prone, lying supine) and appropriate stimulation settings are identified for each position. As the position changes, preferred stimulation settings are found by adjusting the amplitudes of multiple programs. By using multiple programs, the parameters of amplitude, pulse width, rate, and electrodes can be tailored to a patient’s therapy needs. In a clinical study involving 79 patients implanted with the RestoreSensor system, 86.5% of patients achieved the primary objective of improved pain relief with no loss of convenience or improved convenience with no loss of pain relief using automatic position-adaptive stimulation compared to using conventional manual programming adjustment alone ( ). Additionally, position-adaptive stimulation demonstrated a statistically significant 41% reduction in the daily average number of programming button presses for amplitude adjustment compared with manual programming. The adverse event profiles in both treatment groups were similar, and no unanticipated adverse device effects were reported. The study demonstrated that automatic position-adaptive stimulation is safe and effective in providing benefits in terms of patient-reported improved pain relief and convenience compared with using manual programming adjustment alone.
Saluda Medical is currently developing a closed-loop system (Evoke) to adjust stimulation automatically for pain relief using the ECAP as a feedback signal. In acute evaluations of SCS with feedback control, seven of eight subjects evaluated had fewer side-effects and smaller variation in response when compared to conventional fixed-current stimulation ( ). A larger-scale chronic study is currently under way ( ).
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here